Hany Ahmed | Cancer Biology | Best Scholar Award

Published on by Molecular Biologist

 

Best Scholar Award

Hany Ahmed
Al Azhar University , Egypt

Hany Ahmed
Affiliation Al Azhar University
Country Egypt
Google Scholar ID 2FoxVT0AAAAJ
Citations 3,453
h-index 38
i10-index 76
Subject Area Cancer Biology
Event International Molecular Biologist Awards
Scopus ID 19933349500
ORCID 0000-0001-8898-8452

Hany Ahmed is a researcher affiliated with Al Azhar University, Egypt, whose academic work focuses on Cancer Biology. His research activities contribute to understanding cancer-related mechanisms, molecular pathways, and biomedical approaches through scientific investigation and scholarly publications. [1]

Abstract

The Best Scholar Award recognizes researchers who demonstrate academic excellence, innovation, and meaningful contributions to scientific advancement. Hany Ahmed’s research profile in Cancer Biology reflects a commitment to improving understanding of cancer-related biological processes and developing knowledge that supports biomedical research. [2]

Keywords

  • Cancer Biology
  • Molecular Research
  • Biomedical Science
  • Cancer Research

Introduction

Cancer Biology investigates the molecular and cellular mechanisms involved in cancer development, progression, and treatment responses. Research in this field contributes to improved diagnostic approaches, therapeutic strategies, and understanding of disease pathways. Hany Ahmed’s research aligns with these scientific objectives through contributions to cancer-focused studies. [3]

Research Profile

Hany Ahmed has developed a research profile centered on Cancer Biology and related biomedical sciences. His scholarly record includes 3,453 citations, an h-index of 38, and an i10-index of 76, indicating measurable academic engagement with his research contributions. [1]

Research Contributions

  • Investigation of cancer-related molecular mechanisms.
  • Contribution to biomedical and biological research studies.
  • Advancement of scientific knowledge through academic publications.

Publications

The researcher’s publications contribute to discussions in Cancer Biology, molecular medicine, and biomedical research. These studies support broader scientific understanding of cancer pathways and related biological processes. [4]

Research Impact

Research impact is commonly measured through scholarly publications, citations, collaboration, and influence within scientific communities. Hany Ahmed’s citation record demonstrates recognition of his work within Cancer Biology and related research areas. [2]

Award Suitability

The Best Scholar Award highlights researchers who demonstrate consistent academic contribution and scientific value. Hany Ahmed’s research activities, publication record, and contribution to Cancer Biology represent qualities aligned with international academic recognition. [5]

Conclusion

Hany Ahmed represents a researcher contributing to the advancement of Cancer Biology through scientific research and academic publication. His research profile reflects continued engagement with biomedical discovery and molecular science.

References

  1. Elsevier. (n.d.). Scopus author details: Hany Ahmed, Author ID 19933349500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=19933349500
  2. ORCID. (n.d.). Hany Ahmed ORCID Researcher Profile.
    https://orcid.org/0000-0001-8898-8452
  3. Google Scholar. (n.d.). Hany Ahmed Scholar Citation Profile.
    https://scholar.google.com/citations?user=2FoxVT0AAAAJ&hl=a
  4. Hany Ahmed. (2025). synthesis and biological evaluation: New Dimensions. wiley.
    https://doi.org/10.1158/2159-8290.CD-21-1059
  5. International Molecular Biologist Awards. (n.d.). Award Information Portal.
    https://molecularbiologist.org/

 

Yu Chieh Su | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.